Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by Physicians who Treat Acne Vulgaris (US)

Articles with lock require a subscription to GLG News | Request a free trial
Sunil DhawanFebruary 26, 2007
Ceragenix Epiceram product has good potential to be effective in eczema and other skin conditions
Analysis of: Ceragenix Completes Patient Visits for EpiCeram Clinical Study | www.pharmalive.com
Author: Sunil Dhawan, Clinical Assistant Professor of Dermatology, Stanford University
Ceragenix's new product Epiceram, the Barrier repair cream has potential merit and efficacy comparable to mid strength topical steroids:1. Barrier repair has been found to be antiinflammatory.2. The product in mouse studies has effects comparable to steroid creams.3. The product will have less/ minimal...
Sunil DhawanFebruary 26, 2007
CNTO 1275 will have an impact on the psoriasis market
Analysis of: Centocor, Inc. Releases Phase 2 Data on Novel Biologic CNTO 1275 Targeting Chronic Plaque Psoriasis | pharmalive.com
Author: Sunil Dhawan, Clinical Assistant Professor of Dermatology, Stanford University
Centocor's product CNTO1275 will have a major and sustained impact on the market:1. Its PASI 75 reduction is better than the current injectables other than Centocor's Infliximab, which requires a complicated IV infusion.2. Side effects are comparable to other agents.3. It is specifically being developed...
Sunil DhawanFebruary 26, 2007
Will the OTC laser hair systems have an impact??
Analysis of: Palomar and Gillette Expand Their Collaboration to Develop and Commercialize an Additional Light-Based Hair Removal Device for Home Use | phx.corporate-ir.net
Author: Sunil Dhawan, Clinical Assistant Professor of Dermatology, Stanford University
Implications: Palomar and Gillette’s venture in the direct to consumer sale of a light based laser device has several issues that will effect the ability of this venture to be successful 1. The device is only approved for non facial areas, and is only temporarily effective with less than 10% reduction-...

Previous Page : 1 2 3 4 5 6 7 871 to 73 of 73

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-12-01T21:45:56.203